This study reveals that the downregulation of PCP4, potentially due to PCP4 gene deletion, drives the progression of PCa, particularly CRPC, through modulation of Ca2+/CaM/CAMKK2/AMPK/AR signaling axis (Figure 7). The gene discussed is CAMKK2; the disease is posterior cortical atrophy.